Valtrate

CAS: 18296-44-1

Ref. 3D-FV72009

Informação sobre produto

• Nome: Valtrate
• Sinónimos: (1S,6S,7R,7aS)-4-(Acetoxymethyl)-6,7a-dihydro-1H-spiro[cyclopenta[c]pyran-7,2'-oxirane]-1,6-diyl bis(3-methylbutanoate), (1S,6S,7R,7aS)-4-[(acetyloxy)methyl]-6,7a-dihydro-1H-spiro[cyclopenta[c]pyran-7,2'-oxirane]-1,6-diyl bis(3-methylbutanoate), (1S,6S,7aS)-4-[(acetyloxy)methyl]-6,7a-dihydro-1H-spiro[cyclopenta[c]pyran-7,2'-oxirane]-1,6-diyl bis(3-methylbutanoate), (1S-(1a,6a,7b,7aa))-3-Methylbutanoic Acid 4-((Acetyloxy)methyl)-6,7a-dihydrospiro(cyclopenta[c]pyran-7(1H),2'-oxirane)-1,6-diyl Ester, 18296-44-1, Baldrisedon, Butanoic acid, 3-methyl-, (1S,2′R,6S,7aS)-4-[(acetyloxy)methyl]-6,7a-dihydrospiro[cyclopenta[c]pyran-7(1H),2′-oxirane]-1,6-diyl ester, Butanoic acid, 3-methyl-, 1,1′-[(1S,2′R,6S,7aS)-4-[(acetyloxy)methyl]-6,7a-dihydrospiro[cyclopenta[c]pyran-7(1H),2′-oxirane]-1,6-diyl] ester, Butanoic acid, 3-methyl-, 4-[(acetyloxy)methyl]-6,7a-dihydrospiro[cyclopenta[c]pyran-7(1H),2′-oxirane]-1,6-diyl ester, [1S-(1α,6α,7β,7aα)]-, Halazuchrome B, Spiro[cyclopenta[c]pyran-7(1H),2′-oxirane], butanoic acid deriv., Valepotriate, Valtrate [INN], Valtratum, butanoic acid, 3-methyl-, (1S,6S,7R,7aS)-4-[(acetyloxy)methyl]-6,7a-dihydrospiro[cyclopenta[c]pyran-7(1H),2'-oxirane]-1,6-diyl ester

Descrição

Valtrate is a natural compound extracted from the roots of Valeriana officinalis and is used as an herbal remedy for anxiety, insomnia, and epilepsy. It has also been used as an anti-inflammatory agent in the treatment of hepatic steatosis. The extraction process is optimized by a technique called preparative hplc. This extraction process can be monitored with analytical methods such as methyl ethyl assay or high-performance liquid chromatography (HPLC). Valtrate has shown to have a toxicological profile that is not associated with serious adverse effects. In vitro studies revealed that valtrate induces autophagy and promotes locomotor activity in mice. A molecular docking study showed that valtrate binds to receptor molecule GPR55 to inhibit its activation by ligands such as lysophosphatidic acid (LPA).

• Marca: Biosynth

Propriedades químicas

• Peso molecular: 422.47 g/mol
• Fórmula: C₂₂H₃₀O₈
• Pureza: Min. 95%
• Cor/forma: Powder